Back to Startups

Retension Pharmaceuticals

Bioscience & Disease Healthcare Systems Personal Health
Bioscience & Disease Healthcare Systems Personal Health Show less
Bioscience & Disease Healthcare Systems +1
Bioscience & Disease Healthcare Systems Personal Health Show less
Website LinkedIn
About Retension Pharmaceuticals

Retension Pharmaceuticals is a clinical-stage biopharmaceutical startup focused on developing effective treatments for hypertension and cardiovascular health. The company aims to optimize blood pressure management through innovative therapies.

Business Information
Target Customers
healthcare providers patients with hypertension pharmaceutical distributors
Industry Categories
Bioscience & Disease Healthcare Systems Personal Health
Business Model
Revenue Model pharmaceutical sales
Pricing Strategy market-based pricing
Sales Channels direct sales, partnerships with healthcare institutions
Funding Timeline
Round Date Amount Investors
Series B Aug 09, 2025 $15.0M Unknown
Founders

No founder information available.

Investors

No investor information available.

Recent Mentions
raisingfi
Raising.fi @raisingfi
Aug 09, 2025

New Raise 🏛️ Company: Retension Pharmaceuticals 🔗 Website: https://t.co/KrN5FXMXzw 📊 Amount: $15 Million 🔄 Round: Series B 🧮 Valuation: N/A ⚙️ Industry: Biotechnology, Healthcare

View on Twitter
Similar Startups
Renasant Bio
86% match

Developing treatments for genetic kidney diseases.
Retym
85% match

Commercializing programmable coherent DSPs for AI/data-center optics.
Rena Labs
84% match

Rena Labs is an innovative startup focused on developing cutting-edge solutions in the health tech i...
CureGene Pharma
84% match

CureGene focuses on therapeutic areas including cardiovascular and metabolic diseases, developing in...